{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:39:17Z","timestamp":1792741157850,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.vaccine.2012.07.026","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T02:01:26Z","timestamp":1343095286000},"page":"5839-5843","source":"Crossref","is-referenced-by-count":6,"title":["Vaccine trials in the developing world: Operational lessons learnt from a phase IV poliomyelitis vaccine trial in South Africa"],"prefix":"10.1016","volume":"30","author":[{"given":"H.","family":"Geldenhuys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Waggie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Geldenhuys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Traut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tameris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hatherill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.A.","family":"Hanekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Mahomed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 Suppl.","key":"10.1016\/j.vaccine.2012.07.026_bib0005","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/nm1225","article-title":"Introducing new vaccines into developing countries: obstacles, opportunities and complexities","volume":"11","author":"Clemens","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2012.07.026_bib0010","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pctr.0010016","article-title":"Operational challenges in large clinical trials: examples and lessons learned from the gambia pneumococcal vaccine trial","volume":"1","author":"Cutts","year":"2006","journal-title":"PLoS Clin Trials"},{"issue":"2","key":"10.1016\/j.vaccine.2012.07.026_bib0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/infdis\/jir721","article-title":"Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa","volume":"205","author":"Waggie","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.026_bib0020","first-page":"10","article-title":"The novel TB vaccine, AERAS-402, induces robust and polyfunctional CD4 and CD8 T cells in adults","volume":"2010","author":"Abel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.vaccine.2012.07.026_bib0025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"Hawkridge","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2012.07.026_bib0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.200939754","article-title":"Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells","volume":"40","author":"Scriba","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2012.07.026_bib0035","doi-asserted-by":"crossref","first-page":"a2052","DOI":"10.1136\/bmj.a2052","article-title":"Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial","volume":"337","author":"Hawkridge","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.07.026_bib0040","series-title":"Annual health status report","author":"English","year":"2008"},{"key":"10.1016\/j.vaccine.2012.07.026_bib0045","series-title":"The district health barometer 2007\/8","author":"Barron","year":"2008"},{"key":"10.1016\/j.vaccine.2012.07.026_bib0050","series-title":"Guidelines for good clinical practice in the conduct of clinical trials with human participants in South Africa","author":"SA Department of Health","year":"2006"},{"key":"10.1016\/j.vaccine.2012.07.026_bib0055","first-page":"22","article-title":"A professional development model in clinical research for developing countries","author":"Silver","year":"2008","journal-title":"Monitor"},{"issue":"55","key":"10.1016\/j.vaccine.2012.07.026_bib0060","article-title":"Teaching clinical research to all: the Aeras-SATVI\/UCT Professional Development Programme","volume":"9","author":"Geldenhuys","year":"2005","journal-title":"Prof Nurs Today"},{"issue":"4 Suppl.","key":"10.1016\/j.vaccine.2012.07.026_bib0065","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1016\/0197-2456(87)90004-3","article-title":"Recruitment experience in clinical trials: literature summary and annotated bibliography","volume":"8","author":"Hunninghake","year":"1987","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.vaccine.2012.07.026_bib0070","series-title":"Product information sheets","author":"World Health Organization","year":"2000"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12010286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12010286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T23:51:43Z","timestamp":1542844303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12010286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":14,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0264410X12010286"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}